Biotech

Startups

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 15.11.2022.

#biotech
#lifesciences
#lynn
#biomanufacturing
#newengland
#communities

@IAmBiotech shared
On Nov 10, 2022
USDA is seeking input on a gene-edited American chestnut tree, which has been awaiting regulatory approval. Plus, scientists are closing in on the “fountain of rejuvenation,” thanks to biotech. https://t.co/rZ86wm1y7t
Open
Good Day BIO: USDA seeks input on blight-resistant tree – plus, has biotech found the fountain of youth?

Good Day BIO: USDA seeks input on blight-resistant tree – plus, has biotech found the fountain of youth?

USDA is seeking input on a gene-edited American chestnut tree, which has been awaiting regulatory approval. Plus, scientists are closing in on the “fountain of rejuvenation,” thanks to ...

@BentheFidler shared
On Nov 9, 2022
Arrowhead capitalizes on Amgen drug progress with royalty rights deal https://t.co/sMaUoqiZxG by @NedPagliarulo $AMGN $ARWR $RPRX $NVS
Open
Arrowhead capitalizes on Amgen drug progress with royalty rights deal

Arrowhead capitalizes on Amgen drug progress with royalty rights deal

The biotech will sell its royalty interest in a heart disease drug Amgen is developing for $250 million, extending its operating runway by several quarters.

@big4bio shared
On Nov 10, 2022
A #biotech investor says founders should be 'more relentless than ever' when trying to raise funds during the current market downturn https://t.co/ULKBzIIVNn via @businessinsider
Open
A biotech investor says founders should be 'more relentless than ever' when trying to raise funds during the current market downturn

A biotech investor says founders should be 'more relentless than ever' when trying to raise funds during the current market downturn

The economic slowdown is making it harder for biotech founders to raise money. An investor says founders should be creative and aggressive when trying to raise more capital.

@ScottKirsner shared
On Nov 12, 2022
Head of @MassBio #biotech trade group is out after serving just over a year https://t.co/vclTf69YXq via @BostonGlobe
Open
Head of MassBio trade group is out after serving just over a year

Head of MassBio trade group is out after serving just over a year

The abrupt leadership changes comes at a sensitive time for MassBio, which lobbies for the state’s biotechnolology industry, a pillar of the Massachusetts economy.

@BentheFidler shared
On Nov 10, 2022
Biogen names former Sanofi head Viehbacher to replace Vounatsos as CEO https://t.co/RZP05lKLdl $BIIB $SNY
Open
Biogen names former Sanofi head Viehbacher to replace Vounatsos as CEO

Biogen names former Sanofi head Viehbacher to replace Vounatsos as CEO

Viehbacher’s appointment ends a monthslong search by Biogen for new leadership and puts the embattled biotech on a new course after the disastrous launch of Aduhelm.

@matthewherper shared
On Nov 10, 2022
Young life science researchers are leaving academia at unprecedented levels for lucrative jobs in the private sector. Great feature by @JonathanWosen. https://t.co/SY6tSO0SSo
Open
‘The tipping point is coming’: Unprecedented exodus of young life scientists is shaking up academia

‘The tipping point is coming’: Unprecedented exodus of young life scientists is shaking up academia

Faculty are struggling to hire postdocs, delaying research projects and pressuring universities to consider improving salaries and benefits as endowments are shrinking.

@MALifeSciences shared
On Nov 14, 2022
RT @BioConnectsNE: Our co-PI @AuclairJared teamed up with @LynnCityHall and @MayorNicholson to make the case for #biotech expansion in the city. Check it out in @CommonWealthMag #lifesciences #lynn #biomanufacturing https://t.co/ClrVrlh0nk https://t.co/EnRpIM8tmn
Open
Biotech’s next destination: Why not Lynn?

Biotech’s next destination: Why not Lynn?

AFFECTIONATELY KNOWN as an industrial hub hundreds of years ago, Lynn became known as the “shoe center of the new world” by the 1800s, thanks to the establishment and growth of the first ...

@Forbes shared
On Nov 10, 2022
‘Beware' Of Crypto Investing Or Risk Ending Up In Bankruptcy Court, SEC Chair Warns https://t.co/97t1oanAqy https://t.co/HbdDA88vjp
Open
‘Beware' Of Crypto Investing Or Risk Ending Up In Bankruptcy Court, SEC Chair Warns

‘Beware' Of Crypto Investing Or Risk Ending Up In Bankruptcy Court, SEC Chair Warns

Individuals awaiting the fulfillment of their withdrawal requests from FTX are in jeopardy of never seeing their holdings again if the exchange doesn’t find a new partner to save it from ...